| PharmaSUG |
2025 |
Roadmap to Efficacy Analysis for Early Phase Oncology studies |
Dhruv Bansal, Christiana Hawn, Chris Kelly |
source |
23 |
| PharmaSUG |
2018 |
Leveraging Standards for Effective Visualization of Early Efficacy in Clinical Trial Oncology Studies |
Kelci J. Miclaus, Lili Li |
source |
12 |
| PharmaSUG |
2017 |
Where Is the Link Broken - Another Look at SDTM Oncology Tumor Packages |
Hong Wang, Ke Xiao |
source |
12 |
| WUSS |
2016 |
Why and What Standards for Oncology Studies (Solid Tumor, Lymphoma and Leukemia)? |
Kevin Lee |
source |
7 |
| PharmaSUG |
2015 |
Two different use cases to obtain best responses using RECIST 1.1: SDTM and ADaM |
Kevin Lee, Vikash Jain |
source |
17 |
| PHUSE EU |
2014 |
Implementation of Oncology Specific SDTM Domains |
Jacintha Eben |
source presentation source |
8 |